Non-teratogenic health concerns are pregnancy-related risks that affect a baby’s growth, organ function, or long-term health without causing structural birth defects. While teratogens cause visible malformations like cleft palate or limb abnormalities, many exposures and conditions during pregnancy create problems that are harder to see but no less serious: restricted growth, metabolic changes, neurological effects, and vulnerability to infection. These functional and developmental outcomes make up a large portion of pregnancy complications.
How Non-Teratogenic Risks Differ From Birth Defects
A teratogen is any agent that significantly increases the occurrence of irreversible structural abnormalities in a developing baby. Non-teratogenic concerns, by contrast, involve developmental toxicity that doesn’t produce malformations. Some substances cause growth retardation and embryo death without ever creating a structural defect. These agents are classified as embryotoxic rather than teratogenic. For certain exposures, growth restriction, pregnancy loss, and birth defects represent different degrees of the same underlying injury to cells. For others, the damage is qualitatively different, leading to only one type of outcome.
This distinction matters because screening for birth defects (through ultrasound and genetic testing) won’t catch most non-teratogenic problems. A baby can have no visible abnormalities at birth and still face consequences from what happened in the womb, sometimes consequences that don’t become apparent for years.
Fetal Growth Restriction
One of the most common non-teratogenic concerns is fetal growth restriction, where a baby grows more slowly than expected without having a structural defect. The most frequent cause is uteroplacental insufficiency, a condition where the blood vessels supplying the placenta don’t develop properly, limiting the oxygen and nutrients reaching the baby.
Placental problems that contribute to growth restriction include abnormal placenta shape, placental abruption (partial detachment from the uterine wall), infarction, and umbilical cord abnormalities like a single artery or unusual cord insertion. Placental inflammation is another recognized mechanism. None of these cause malformations, but they can significantly affect birth weight and organ development.
Maternal health conditions also play a major role. Chronic high blood pressure, diabetes (gestational or pre-existing), lupus, antiphospholipid syndrome, severe kidney or heart disease, and sickle cell disease all interfere with blood flow between mother and baby. Substance use during pregnancy, including alcohol, cocaine, nicotine, heroin, and marijuana, is strongly associated with smaller-than-expected babies. Even factors like low pre-pregnancy weight, poor weight gain during pregnancy, carrying multiples, and living at high altitude contribute to growth restriction without causing birth defects.
Gestational Diabetes and Metabolic Effects
Gestational diabetes creates a different growth problem: babies that are too large rather than too small. High maternal blood sugar crosses the placenta and stimulates the baby to produce extra insulin, which acts as a growth hormone. This increases the risk of a difficult delivery and cesarean section. Beyond the immediate birth complications, babies born to mothers with any type of diabetes face higher rates of childhood obesity and type 2 diabetes later in life. These are metabolic consequences, not structural ones, and they illustrate how the womb environment can program a child’s health trajectory for decades.
Preeclampsia’s Long-Term Impact on Children
Preeclampsia, a dangerous rise in blood pressure during pregnancy, is well known for its risks to the mother. Its effects on the baby extend far beyond the newborn period. Children exposed to preeclampsia in the womb have measurably higher blood pressure during childhood and into early adulthood, with systolic pressure averaging 2.39 mmHg higher and diastolic pressure 1.35 mmHg higher than unexposed children, based on a meta-analysis of eighteen studies.
Those numbers may sound small, but at a population level the corresponding elevation in systolic blood pressure translates to an 8% increase in mortality from heart disease and a 12% increase in stroke deaths. Preeclampsia also considerably raises the child’s risk of obesity and other long-term hormonal and metabolic problems. None of these outcomes involve a malformation visible at birth.
Neurodevelopmental Effects From Maternal Stress and Obesity
The developing brain is especially sensitive to conditions in the womb that have nothing to do with structural damage. Maternal stress during pregnancy exposes the fetus to elevated cortisol, and research using brain imaging has shown that higher prenatal cortisol levels are associated with larger amygdala volume in children. The amygdala is a brain region involved in processing fear and emotion, and the increase in its size partially explains why these children show more symptoms of depression and mood problems. This effect appears stronger in girls than boys.
Maternal obesity before and during pregnancy has its own neurodevelopmental footprint. Children born to obese mothers show a 2.8-fold increase in ADHD symptoms compared to children of non-obese mothers. Notably, it was the mother’s weight before pregnancy, not how much weight she gained during pregnancy, that predicted this outcome. These findings reflect a concept called fetal programming: the idea that conditions in the womb shape the brain’s wiring and influence susceptibility to mental health disorders throughout life.
Neonatal Effects From Antidepressant Use
Antidepressants in the SSRI class are not considered teratogenic at standard doses, but they can cause a temporary withdrawal-like condition in newborns called neonatal SSRI withdrawal syndrome. Symptoms typically appear within the first 48 hours after birth. Babies who show no signs by 48 hours are extremely unlikely to develop them.
The syndrome follows a general pattern: an initial phase of low muscle tone and poor sucking, followed by a period of increased irritability, tremors, high-pitched crying, and disrupted sleep. Gastrointestinal symptoms like vomiting, poor feeding, and uncoordinated sucking are common. Some babies develop rapid breathing. Less frequently, temperature instability, sweating, nasal congestion, and skin mottling occur. Seizures are rare. The severity varies depending on the specific medication, the dose, how long the mother took it, and whether other substances were involved. Symptoms resolve within hours to days, and the condition is self-limiting.
Infections That Harm Without Causing Malformations
While certain infections like rubella and cytomegalovirus are known teratogens, others cause serious harm to newborns without producing structural defects. Group B Streptococcus is the leading infectious cause of early-onset neonatal sepsis, and it can also cause pneumonia and meningitis in newborns. Early-onset disease strikes during the first week of life, while late-onset disease can appear anytime in the first three months. Neonatal meningitis is the most common serious bacterial infection in the newborn period, with Group B Strep and E. coli as the primary culprits. These infections are acute medical emergencies, but they don’t involve the kind of developmental malformations associated with teratogenic infections.
Air Pollution and Environmental Exposures
Prenatal exposure to air pollution represents a widespread non-teratogenic risk that affects millions of pregnancies. For every 10 microgram-per-cubic-meter increase in fine particulate matter (PM 2.5) exposure during pregnancy, the odds of a baby being born small for gestational age rise by about 8%. This effect holds across the second and third trimesters.
The consequences extend well past birth. Prenatal air pollution exposure is linked to impaired lung function in infants and children, increased respiratory symptoms, and higher rates of childhood asthma. Postnatal exposure to household air pollution adds a 19% greater incidence of stunted growth. In areas with high particulate pollution, stunting and its related developmental effects are particularly common. Lower birth weight, neonatal jaundice, fetal death, and maternal anemia have all been identified as possible effects of pollution exposure during pregnancy. Arsenic exposure specifically has been connected to reduced birth weight through measurable changes in the baby’s metabolism.
Stillbirth Risk in Older Mothers
Advanced maternal age is a non-teratogenic risk factor that increases the chance of stillbirth without involving structural abnormalities. For pregnant individuals who will be 40 or older at delivery, the American College of Obstetricians and Gynecologists suggests fetal monitoring during the third trimester and recommends delivery between 39 weeks and 39 weeks and 6 days, because rates of stillbirth and newborn complications rise beyond that point. For those aged 35 to 39, routine surveillance isn’t recommended unless other risk factors are present. The optimal timing and frequency of monitoring haven’t been established, but the underlying concern is clear: the placenta’s ability to sustain a pregnancy declines with age, independent of any genetic or structural problem with the baby.